Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part II—The Challenge of Programmed Death Ligand-1 Testing and Its Role in Microsatellite Instability-High Colorectal CancerEsmeralda Celia Marginean, Barbara Melosky|Archives of Pathology & Laboratory Medicine|2017Cited by 38
P1.01-28 Impact of Afatinib Dosing on Safety and Efficacy Real-World in Patients with EGFR Mutation-Positive Advanced NSCLCBalázs Halmos, Enric Carcereny, M.K. Lee et al.|Journal of Thoracic Oncology|2018Cited by 1
Impact de la dose d’afatinib sur la tolérance et l’efficacité en vie réelle chez des patients avec CBNPC avancé EGFR mutéBalázs Halmos, Enric Carcereny, E.H. Tan et al.|Revue des Maladies Respiratoires|2018Cited by 0